Why Is Cartesian Therapeutics (RNAC) Stock Down 5% Today?
RNAC stock is down on a delisting notice Cartesian Therapeutics (NASDAQ:RNAC) stock is falling on Monday after the clinical-stage biopharmaceutical company revealed a delisting notice. This notice comes from the Nasdaq Listing Qualifications department and has to do with the price of RNAC stock.…
#rnac #nasdaqexchange #brileyfinancial #rily #coherusbiosciences #chrs #lifw #williamwhite